Siga Technologies (SIGA) EBT (2010 - 2025)
Siga Technologies' (SIGA) quarterly EBT came in at -$8.4 million in Q3 2025, down 546.22% on a YoY basis from $1.9 million in Q3 2024, and down 117.68% quarter-over-quarter from $47.3 million in Q2 2025.
Analysis
Siga Technologies (SIGA) EBT (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported EBT for 16 consecutive years, with -$8.4 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, EBT fell 546.22% year-over-year to -$8.4 million; the trailing twelve-month figure through Sep 2025 stood at $96.9 million (down 12.17% YoY), and the FY2024 full-year result was $76.1 million, down 13.34% from the prior year.
- EBT eased to -$8.4 million in Q3 2025 per SIGA's latest filing, from $47.3 million in the prior quarter.
- Across five years, EBT topped out at $93.9 million in Q4 2021 and bottomed at -$8.4 million in Q3 2025.
- Historically, EBT has averaged $17.7 million across 5 years, with a median of $467606.0 in 2021.
- The sharpest annual moves came in 2023 and 2025: EBT jumped 8336.91% in 2023, then tumbled 546.22% in 2025.
- Over 5 years, EBT stood at $93.9 million in 2021, then sank by 101.2% to -$1.1 million in 2022, then surged by 8336.91% to $92.9 million in 2023, then plunged by 36.92% to $58.6 million in 2024, then slumped by 114.26% to -$8.4 million in 2025.
- According to Business Quant data, EBT over the past three periods registered -$8.4 million, $47.3 million, and -$570415.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.64 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 751.51 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 372.70 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -8.36 Mn |
| Jun 30, 2025 | 47.27 Mn |
| Mar 31, 2025 | -570,415.00 |
| Dec 31, 2024 | 58.58 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 13.22 Mn |
| Dec 31, 2023 | 92.87 Mn |
| Sep 30, 2023 | -426,096.00 |
| Jun 30, 2023 | -3.45 Mn |
| Mar 31, 2023 | -1.22 Mn |
| Dec 31, 2022 | -1.13 Mn |
| Sep 30, 2022 | 43.13 Mn |
| Jun 30, 2022 | 3.19 Mn |
| Mar 31, 2022 | -1.06 Mn |
| Dec 31, 2021 | 93.87 Mn |
| Sep 30, 2021 | -3.98 Mn |
| Jun 30, 2021 | 467,606.00 |
| Mar 31, 2021 | -1.05 Mn |
| Dec 31, 2020 | 26.25 Mn |